General Division of the High Court · Decided 26 May 2023
Dr Who Waterworks Pte Ltd and others v D r Who (M) Sdn Bhd and others
Feedback & support[2023] SGHC 156 · Case no. Suit No 600 of 2020 (consolidated with Suit No 96 of 2021)
✱ What happened, in plain English
There is no plain-English summary of this judgment yet.
Ask about this judgment →Grounds of decision
Official text from eLitigation
- [1]
[1] This case involves a multiplicity of claims and counterclaims spanning intellectual property, contract and tort. They trace their origins to the acrimonious breakdown of the commercial relationship which once existed between the parties and the acts which followed.
Facts
The parties
- [2]
[2] The first plaintiff is a Singapore company currently known as Dr. Who Waterworks Pte Ltd. Incorporated on 19 February 1998, it was initially named Cana Services Pte Ltd before it took on its present name on 26 September 2002. While parties disagree on the nature of the business which the first plaintiff engaged in prior to the change in its name, it is not disputed that the first plaintiff was engaged in the supply of 5-gallon bottled water and the leasing and placement of water dispensers following its name change. At that point in 2002, the company was jointly operated by Mr Koh Tiong Gee (“Mr Koh”), his wife, Ms Tan Kim Peng (“Mdm Tan”), and Mr Benji Ng Ser Kwei (“Mr Ng”). The first plaintiff expanded its business in 2003 to include the provision of “bottles of water with label design and personalised branding”. For simplicity, I shall refer to such bottles of water as “bottled water bearing the customer’s mark”.
- [3]
[3] The second plaintiff, Dr. Who Global Watertech (S) Pte Ltd, was incorporated by Mr Koh on 27 June 2007. It engaged in the business of supplying and distributing bottled water and took over the segment of the first plaintiff’s business for the provision of bottled water bearing the customer’s mark.
- [4]
[4] The third plaintiff, Dr. Who Laboratories (S) Pte Ltd, was incorporated on 16 April 2008 by Mr Koh for the purposes of research and development. This entity subsequently entered into the direct piping sector to support the plaintiffs’ other businesses.
- [5]
[5] The first defendant, Dr. Who (M) Sdn Bhd, was incorporated in Malaysia on 11 April 2007 by the second defendant, Mr Oo Tim Wee (“Mr Oo”). According to its business profile with the Companies Commission of Malaysia, the first defendant engages in the business of dealing in mineral and aerated water, and the provision of “integrated logistics services”. Mr Oo, Mdm Low Siew Eng (“Mdm Low”) (who is the third defendant), Mr Koh, Mdm Tan and the first plaintiff were the initial shareholders of the first defendant. The first plaintiff subsequently sold its shareholding in the first defendant to the remaining shareholders.
- [6]
[6] The fourth defendant, Dr. Who (S) Pte Ltd, was incorporated in Singapore by the second and third defendants on 17 July 2019. According to its profile provided by the Accounting and Corporate Regulatory Authority (“ACRA”), the fourth defendant’s activities include the “wholesale trade of a variety of goods without a dominant product”, and “other transportation support activities”. Mr Oo and Mdm Low were the only directors of the fourth defendant at the time of its incorporation.
- [8]
[8] Two other companies, D’Choice Pte Ltd (“D’Choice”) and New Global Watertech Pte Ltd (“New Global”), were incorporated by Mr Koh in 2007 for the purposes of corporate restructuring. They are however not parties to these proceedings as they ceased business activities in 2017.
Background to the dispute
The early years of the parties’ commercial relationship
- [9]
[9] I begin with the change in the first plaintiff’s name in September 2002. Mr Koh, who was serving as the general manager of the first plaintiff at the time, testified that he was the “motivator and main decision-maker to all matters concerning the business of the [first] plaintiff”. This included the change in the company’s name. According to Mr Koh, he conceived of the name “DR. WHO” by himself sometime before 26 September 2002. He states that he thought of the prefix “DR” as it harkened to the idea of “the usual doctor’s advice to drink plenty of water”, and the word “WHO” as the abbreviated form of the “World Health Organisation”. The defendants dispute this fact, insisting instead that the name “DR. WHO” was the creation of the prior owners of the first plaintiff before Mr Koh joined as a shareholder.
- [10]
[10] In any case, following this change, Mr Koh became acquainted with Mr Oo through a mutual friend. At that time, Mr Oo was operating a Malaysian company, APlus Water & System Sdn Bhd (“APlus Water”), with his wife, Mdm Low. The company manufactured and supplied bottled water and dispenser services. The first plaintiff then decided to engage APlus Water for their supply and manufacturing services.
- [11]
[11] According to Mr Oo, he was invited by Mr Chan Eng Guan (“Mr Chan”) to invest in the first plaintiff and to become a director in November 2002. Mr Oo agreed. Mr Chan was himself a shareholder and director of the first plaintiff but operated at all times as a sleeping director.
- [12]
[12] As previously mentioned, the first plaintiff expanded its business in 2003 to include the provision of bottled water bearing the customer’s mark. This comprised the supply of bottled water in various sizes (ie, ranging from 250ml to 1.5l bottles). This is illustrated by the following examples:
- [13]
[13] Mr Koh asserts that he was solely responsible for the genesis of this new business concept. APlus Water assisted in the implementation of this business concept by manufacturing and supplying the bottled water bearing the customer’s mark, a role which it undertook from November 2002 to December 2011. This service was later transferred from APlus Water to another company owned by Mr Oo and his brother, APlus Food & Beverage Sdn Bhd (“APlus F&B”).
- [14]
[14] In 2003, several shareholders of the first plaintiff, including Mr Ng, relinquished their shares in the company. Pursuant to an agreement dated 15 March 2004, Mr Koh acquired a majority shareholding in the first plaintiff after Mr Oo and Mr Chan each transferred a portion of their shareholding to him. On 31 March 2004, Mr Chan exited the first plaintiff, leaving Mr Oo and Mr Koh as equal shareholders. Mr Koh was also appointed a director of the first plaintiff in March 2004, a role which he was hitherto unable to take up due to employment disputes with his previous employer.
- [15]
[15] On 17 August 2004, the first plaintiff registered the mark “DR. WHO” in the following classes in Singapore:
Trade Mark No.
Mark
Class
Goods/Services
T0413722F
39
Delivery of bottled water to homes and offices; water supply services
T0413721H
32
Bottled water [not for medical purposes]; oxygenated water; drinking water; aerated water; waters [beverages] other than for medical purposes
I refer to the mark registered in Class 39 as the “DR. WHO services mark” and the mark registered in Class 32 as the “DR. WHO goods mark” (collectively referred to as the “DR. WHO word marks”).
- [16]
[16] Mr Koh and Mr Oo each assert that they were solely responsible for the registration of the DR. WHO word marks. According to Mr Koh, Mr Oo had nothing to do with the registration of the DR. WHO word marks, which were registered on Mr Koh’s sole instructions. Mr Oo, on the other hand, testifies that it was he who decided to register the marks.
- [17]
[17] The first defendant was incorporated in Malaysia on 11 April 2007 to operate as the manufacturing arm of the first plaintiff. According to Mr Koh, this was done as a preparatory step to distance the first plaintiff from its existing suppliers, APlus Water and APlus F&B, due to ongoing disputes between Mr Oo and his brother.
- [18]
[18] On 29 May 2007, a trade mark was registered in Malaysia in Mr Oo’s name. This trade mark bore the words “DR. WHO” with two decorative “swooshes” at the bottom-right corner of the words (“the DR. WHO swoosh mark”).
Trade Mark No
Mark
Class
Goods
07009932
32
Mineral water; drinking water; oxygenated water (for non-medical use); reverse osmosis water; mineralized water (for non-medical use) and aerated water; fruit drinks and fruit juices; vegetable juices; syrups and other preparations (of non-alcoholic) for making beverages; instant beverage powders for preparations of non-alcoholic drinks and beverages
- [19]
[19] Mr Koh’s evidence is that he had created the DR. WHO swoosh mark by himself, and that he and Mdm Tan had agreed that the Malaysia-registered mark was to be registered in the name of the first defendant. However, they only discovered that the DR. WHO swoosh mark was registered in Mr Oo’s name sometime in 2016. Conversely, Mr Oo testifies that Mr Koh was at all times fully aware that the mark was registered in his name.
- [20]
[20] From 2007 to 2008, four companies were incorporated for the purposes of the corporate restructuring and expansion of the first plaintiff’s business: the second plaintiff, D’Choice, New Global and the third plaintiff. Pursuant to the restructuring exercise, the first plaintiff was made the holding company of these preceding companies (collectively, “the Dr. Who Group”). The first plaintiff continued its business of supplying 5-gallon bottled water and bottled water bearing the customer’s mark. It placed orders for bottled water bearing the customer’s mark with New Global and APlus F&B, while supplying the second plaintiff with bottled water, dispenser services and bottled water bearing the customer’s mark. Sometime in January 2012, the first plaintiff began ordering bottled water bearing the customer’s mark from the first defendant and ceased orders from APlus F&B.
- [21]
[21] In 2012, Mr Koh engaged a brand-strategy consultant. This resulted in the development of the slogan “Bringing smiles to your world” (“the Slogan”) and a trade mark based on the words “DR. WHO”. The mark comprised the term “DR. WHO” with four water droplets in a quatrefoil shape at its top-right corner (“the DR. WHO quatrefoil device mark”). The mark was registered in the first plaintiff’s name in Singapore on 19 October 2012 in the following classes:
Trade Mark No.
Mark
Class
Goods/Services
T1215741I
11
Water treatment units
40
Treatment of water
The breakdown in the parties’ relationship – the First Malaysian Suit and the Deed
- [22]
[22] In 2013, cracks began to form in the business relationship between Mr Koh and Mdm Tan (“the Kohs”) and Mr Oo and Mdm Low (“the Oos”). The deterioration in relations was precipitated by disputes over, inter alia, each party’s remuneration and the Kohs’ employment of their relatives. This culminated in the initiation of a suit by the Kohs against the Oos in Malaysia on 6 September 2016 (“the First Malaysian Suit”). The suit involved the claim by the Kohs that the Oos had wrongfully made unilateral attempts to increase the salary which Mdm Low received from the first defendant.
- [23]
[23] Three days after the commencement of the First Malaysian Suit, on 9 September 2016, Mr Oo registered in Malaysia a mark containing the words “DR. WHO” with the quatrefoil-water droplet design element affixed at the top-right hand corner (“the Malaysian DR. WHO quatrefoil device mark”):
Trade Mark No.
Mark
Class
Goods/Services
2016066646
32
Mineral water; flavoured mineral water; mineralized water (for non-medical use); drinking water; flavoured waters; oxygenated water (for non-medical use); reverse osmosis water; aerated water; energy drinks
Mr Koh’s evidence is that, at the time, he was unaware that Mr Oo had registered the mark.
- [24]
[24] The Kohs and the Oos were eventually able to reach a settlement regarding the First Malaysian Suit and recorded the terms of their agreement in a deed of settlement dated 13 February 2017 (“the Deed”). The parties to the Deed were, on one hand, the Dr. Who Group and the Kohs; and on the other, the first defendant and the Oos. The Deed essentially envisaged a parting of ways between the Oos and the Kohs in terms of the shareholdings and directorships they each held in the Singaporean and Malaysian companies. This was due to, as the recital of the Deed termed it, “irreconcilable disputes and differences” between the parties. Pursuant to the Deed, the Kohs became the only shareholders and directors of the first to third plaintiffs, New Global and D’Choice, while the Oos became the only shareholders and directors of the first defendant.
- [25]
[25] The Deed also governed the intellectual property held by the respective companies. Pertinently, Clause 2.3 of the Deed dealt with the “rights of ownership of “DR. WHO” marks”, and provided as follows:
The events following the Deed
- [26]
[26] After the settlement, the plaintiffs continued to place orders for bottled water bearing the customer’s mark from the first defendant.
- [27]
[27] On 29 October 2018, Mr Oo registered in Malaysia two marks that comprised the words “DR. WHO” in Classes 16 and 35 respectively (collectively, “the Malaysian DR. WHO word marks”):
Trade Mark No
Mark
Class
Goods/Services
2018072778
16
Advertising posters; advertising publications; photographs; paper cards (blank) for recording data; envelopes; business cards; paper bags; packaging materials made of cardboard; paper boxes; printed forms; booklets; books; leaflets; letterhead paper; paper for letterhead paper; writing paper; note pads; pamphlets; leaflets; stickers; paper tags; user manuals (in the form of printed matter); company magazines; catalogues; newsletters; periodicals; brochures; gift stationery
2018072780
35
- [28]
[28] Sometime in late 2018, Mr Koh came to learn from one of the Dr. Who Group’s customers that the first defendant was supplying bottled water bearing the customer’s mark to a competitor of the plaintiffs, Global Water Solutions Pte Ltd (“Global Water”). The first plaintiff decided to engage DP Quest Investigation Consultancy Pte Ltd (“DP Quest”) to conduct surveillance on the first defendant’s activities in Singapore.
- [29]
[29] DP Quest’s findings were contained in a report dated 6 December 2019 (“the PI Report”). The report made the following findings:
(a) On 28 March 2019, a truck with vehicle registration number JTF 7514 bearing a trailer (“Vehicle A”) was seen driving into the first plaintiff’s premises at 24 Chin Bee Road. As evident from the photograph below, on Vehicle A was the sign “DR. WHO” with four water droplets in a quatrefoil design on its top right corner (“the DR. WHO quatrefoil device sign”), followed by the first defendant’s contact details, e-mail “drwho@drwho.com.my” and website “www.drwho.com.my”.
(b) On 10 April 2019, Vehicle A was seen at Global Water’s premises at 1 Venture Avenue (“Global Water’s old premises”). It contained as its cargo empty bottles with labels bearing either the words “Hydr8” or “Royal”. There were no clear photographs provided of the allegedly infringing signs on Vehicle A on this occasion.
(c) On 7 May 2019, a truck with vehicle registration number JRU 617 (“Vehicle B”) was seen at Global Water’s old premises. According to the PI Report, the first defendant’s name, the “Dr WHO logo and Malaysian contact details” were displayed on the truck, although there were no photographs showing that these allegedly infringing signs were clearly displayed on Vehicle B.
(d) On 27 May 2019, Vehicle A was seen picking up boxes containing empty bottles with the label “Hydr8” from Global Water’s old premises. Vehicle A bore the same allegedly infringing signs as it did when it was sighted on 28 March 2019. This is evidenced by the following photograph provided by the PI Report.
(e) On 15 October 2019, Vehicle A was seen parked at Global Water’s premises at 35 Pioneer Road North (“Global Water’s new premises”). Empty “Hydr8” bottles were loaded onto Vehicle A. On this particular occasion, the PI Report showed that the DR. WHO quatrefoil device sign was also used on the polo shirt worn by Vehicle A’s driver (“Driver A’s Attire”). It was also revealed that the first defendant’s name was displayed on the side of Vehicle A and that the “www.drwho.com.my” sign was painted on the front of Vehicle A. The following photographs presented in the PI Report confirm these findings.
- [30]
[30] I also observe that Mr Koh alleges in his affidavit the use of multiple infringing signs on Vehicles A and B which are not directly evidenced by the PI Report. For instance, he asserts that the attire of Vehicle A’s driver bore various infringing signs on 28 March 2019 and that the plaintiffs’ website address (“www.drwhohub.com”) was displayed on Vehicle B on 7 May 2019. Neither the findings of the PI Report nor the photographs therein corroborate these assertions.
- [31]
[31] In addition to Vehicles A and B, Mr Koh’s evidence is that two other vehicles with vehicle registration numbers JNY 3452 and JSX 5217 respectively also bore the following details: the DR. WHO quatrefoil device sign, the Slogan, the “www.drwho.com.my” sign, the first defendant’s e-mail and contact numbers and the plaintiffs’ e-mail. I refer to these vehicles as “Vehicle C” and “Vehicle D” respectively, and all four of these commercial vehicles collectively as “the Commercial Vehicles”.
- [32]
[32] As a result of the PI Report and Mr Koh’s “connections… in the market”, Mr Koh discovered that the first defendant was selling bottled water bearing the customer’s mark to the following companies in Singapore after the signing of the Deed:
(a) Picco Enterprise Pte Ltd;
(b) Global Water;
(c) Royal JC Pte Ltd;
(d) GSH Marketing (S) Pte Ltd; and
(e) Hock Leong Teck Kee Pte Ltd.
- [33]
[33] Mr Oo does not deny that the first defendant had in fact sold bottled water to the aforementioned companies but maintains that he was entitled to do so under the Deed as long as he did not use the “DR. WHO” mark. Mr Oo also testified that, in addition to the above companies, the first defendant supplied bottled water to one Field Catering & Supplies Pte Ltd. It is undisputed that none of the bottles supplied to these companies bore the mark “DR. WHO” or any of the marks in issue in these proceedings.
- [34]
[34] On 7 August 2019, the first plaintiff, through its solicitors, proceeded to send to the companies listed at [32] above letters of demand, asking that they refrain from engaging the first defendant for the sale of bottled water in a manner which would amount to passing off or a breach of the Deed. A letter of demand was also sent to the defendants on the same day, alleging that they were liable for passing off and trade mark infringement of the DR. WHO word marks and the DR. WHO quatrefoil device mark by the use of identical or similar marks on their vehicles, and were in breach of the Deed. The first defendant replied on 29 August 2019 denying any liability. Meanwhile, the Oos had incorporated the fourth defendant, DR. WHO (S) Pte Ltd, in Singapore on 17 July 2019.
- [35]
[35] Although, as observed at [26], the plaintiffs continued their orders for the manufacturing of bottled water from the first defendant, these orders were gradually reduced. This resulted in the plaintiffs entering into various transactions with other manufacturers, which are summarised as follows:
(a) On 10 June 2019, the second plaintiff entered into a distribution agreement with a Malaysian company, Water Revelation Sdn Bhd (“WRM”), and its Singaporean arm, Water Revelation (S) Pte Ltd (“WRS”). These two companies were in the business of bottling and distributing pure drinking water respectively. Under this agreement (“the Distribution Agreement”), the second plaintiff was to print labels (for the purpose of affixing them on bottled water) and deliver them to WRM’s premises in Malaysia. WRM would apply these labels to bottled water, which it then supplied to the second plaintiff for the onward distribution of the same to the second plaintiff’s customers in Singapore. Mr Koh’s evidence is that the first and second defendants had knowledge of the Distribution Agreement through a conversation he had with Mr Oo. Mr Oo’s evidence, on the other hand, is that no such conversation took place. According to Mr Oo, he came to learn of the Distribution Agreement on 21 July 2020, when carton boxes bearing the DR. WHO word marks and the DR. WHO quatrefoil device mark containing bottled drinking water were seen loaded up on a vehicle with registration number JGW6630.
(b) Jasinpack Sdn Bhd (“Jasinpack”), from 13 February 2017 to 18 August 2020, printed and supplied labels bearing the DR. WHO word marks to the second plaintiff.
(c) Win Smith Sdn Bhd (“Win Smith”), from 2019 to 2020, printed and supplied labels bearing the DR. WHO word marks and the DR. WHO quatrefoil device mark to either WRM on the second plaintiff’s account, or directly to the second plaintiff.
(d) Profile Label Sdn Bhd (“Profile Label”), from 13 February 2017 to 18 August 2020, printed and supplied labels bearing the DR. WHO word marks to WRM on the second plaintiff’s account.
(e) Lian Huat Sdn Bhd (“Lian Huat”) and Ornapaper Sdn Bhd manufactured carton boxes that bore the DR. WHO word marks and the DR. WHO quatrefoil device mark and the plaintiffs’ contact details. These boxes were supplied to WRM on the second plaintiff’s account.
- [36]
[36] In early 2020, the Kohs accessed the “www.drwho.com.my” website and discovered that it contained, amongst other things:
(a) the title “DR. WHO (M) Sdn Bhd”;
(b) a banner which bore the DR. WHO quatrefoil device sign;
(c) an image of a building bearing the DR. WHO quatrefoil device sign;
(d) the first defendant’s contact details and address; and
(e) a link to the first defendant’s Facebook page (“the DR. WHO (M) Facebook page”). The DR. WHO (M) Facebook page also bore the same details listed in the preceding sub-paragraphs, as well as a link to another website belonging to the defendants, “www.drwho.asia”.
- [37]
[37] Between January and March 2020, the Kohs also came to learn that the IKEA stores at 60 Tampines North Drive (“IKEA Tampines”) and 317 Alexandra Road (“IKEA Alexandra”) were selling 500ml cartons of drinking water bearing the sign “DRICKSVATTEN” (“the Cartons”). Mr Oo’s evidence is that the fourth defendant had an agreement with IKEA for the sale of the Cartons that began sometime in January 2019. As the following photograph demonstrates, the Cartons also bore, at the bottom in fine print, the following:
(a) the sign “Dr. Who (M) Sdn Bhd” and the first defendant’s address in Malaysia;
(b) the first defendant’s telephone number, fax number and e-mail; and
(c) the “www.drwho.asia” website.
- [39]
[39] The Kohs also accessed the “www.drwho.asia” website. This website had a similar design to the “www.drwho.com.my” website, save that its meta-title bore the name of the fourth defendant and had, at the bottom of the webpage, the following notice: “© 2020 DR. WHO (S) PTE LTD”. To elaborate, meta-titles do not “appear” in the content of the webpage itself. Instead, they set out the “topic” of the webpage and often appear as text in the “tab” of a web browser and as part of search engine results.
The commencement of the present suit and related proceedings
- [40]
[40] Armed with the discoveries above, the plaintiffs commenced the present proceedings on 3 July 2020, asserting that the defendants were liable for, inter alia, the tort of passing off, trade mark infringement and breach of the Deed. The plaintiffs also filed HC/SUM 2651/2020 (“SUM 2651”) on the same day, seeking an interim injunction to restrain the defendants from, amongst other things:
- [41]
[41] After the grant of the Interim Injunction, the plaintiffs’ solicitors wrote to IKEA on 13 July 2020, and, making reference to the Interim Injunction, asked that IKEA “immediately cease and desist from all dealings that concern the sale of [the Cartons]”. IKEA, following discussions with the Oos and their solicitors, proceeded to suspend deliveries from the first defendant on 20 July 2020. Existing Cartons that remained on display at IKEA stores had references to the words “DR. WHO” redacted. IKEA also placed fresh orders for water contained in 500ml cartons from the first defendant with new packaging that made no reference to the first defendant, the “www.drwho.asia” website or its contact details.
- [42]
[42] On 16 July 2020, the plaintiffs’ solicitors wrote to the Registrar of Companies seeking that the Registrar direct the fourth defendant to change its name pursuant to s 27(2) of the Companies Act (Cap 50, 2006 Rev Ed). On 7 August 2020, the fourth defendant received a letter from ACRA directing the fourth defendant to change its name. The fourth defendant complied, and its name was therefore changed from “DR. WHO (S) Pte Ltd” to “Dynamic Watermedia Pte Ltd” on 20 April 2021.
- [43]
[43] On 31 July 2020, the defendants’ solicitors sent a letter of demand to the plaintiffs, alleging that the plaintiffs had (by the various transactions at [35] above) infringed the Malaysian DR. WHO word marks and the Malaysian DR. WHO quatrefoil device mark. According to Mr Koh, it was through this letter that the plaintiffs first came to learn of the registration of the Malaysian DR. WHO word marks and the Malaysian DR. WHO quatrefoil device mark by Mr Oo.
- [45]
[45] On 16 August 2020, the defendants commenced legal proceedings against the first plaintiff and its manufacturers as listed at [35] above (“the Second Malaysian Suit”) for essentially the same causes of action as the counterclaims in the present suit. The defendants were granted an injunction in the Second Malaysian Suit against the second plaintiff, WRM and Lian Huat, restraining them from infringing the Malaysian trade marks registered in Mr Oo’s name until the disposal of those proceedings (“the Malaysian Injunction”).
- [47]
[47] On 11 September 2020, the defendants proceeded to file their defence and counterclaim. Amongst other claims in their counterclaim, the defendants’ case is that from the date of the Deed (13 February 2017) to August 2020, the plaintiffs had placed orders for the supply of bottled water and the printing of labels and carton boxes which bore signs identical to the Malaysian DR. WHO word marks and the Malaysian DR. WHO quatrefoil device mark with various companies in Malaysia in breach of the Deed.
- [48]
[48] On 14 September 2020, the defendants also filed HC/SUM 3928/2020 (“SUM 3928”), which was an application to set aside the Interim Injunction. The defendants took the position that the plaintiffs had wrongfully sought the Interim Injunction to force IKEA to cease selling the Cartons, as the Cartons were characterised as cartons of water rather than bottled water and therefore were not covered by the injunction.
- [51]
[51] With this background set out, I turn to the parties’ cases proper.
The parties’ cases
The plaintiffs’ claims
- [52]
[52] The plaintiffs advance five heads of claim against the defendants. The plaintiffs’ arguments under each head of claim are summarised as follows:
(a) First, the plaintiffs claim that the first and fourth defendants have infringed the DR. WHO word marks and the DR. WHO quatrefoil device mark. They assert that the first and fourth defendants infringed the DR. WHO word marks and DR. WHO quatrefoil device mark by the use of identical or similar signs on: (i) the first defendant’s Commercial Vehicles and on Driver A’s Attire; (ii) the display of the “www.drwho.asia” website on the Cartons on sale at IKEA Alexandra and IKEA Tampines; (iii) the content of the defendants’ websites; (iv) the content of the DR. WHO (M) Facebook page; and (v) the incorporation of the fourth defendant with a name “identical with or similar to the DR. WHO word marks and/or the DR. WHO quatrefoil device mark”. It is averred that these signs were used in relation to “goods or services identical with or similar to” those which the DR. WHO word marks and DR. WHO quatrefoil device mark are registered for. The plaintiffs submit that there is a likelihood of confusion as to the origin of the goods and services in question, which constitutes an infringement under s 27(2) of the TMA.
(b) Second, the plaintiffs claim that the first and fourth defendants are “liable for the tort of passing off”. They argue that goodwill in their business exists vis-à-vis persons in Singapore who did business with the plaintiffs, and that the words “DR. WHO” and their trade marks are identifiers which are associated with their goodwill. The plaintiffs submit that the first and fourth defendants had, by using the words “DR. WHO” and other signs in Singapore, committed various acts which amounted to misrepresentations that the defendants’ goods and/or business were the plaintiffs’ or were otherwise associated with the plaintiffs. The plaintiffs submit that three heads of damage are applicable: the tarnishment of their goodwill, the likelihood of damage should the defendant get into financial, legal or other trouble and the loss of exclusivity or erosion of distinctiveness to their goodwill. In addition, the plaintiffs plead an additional head of damage in their Statement of Claim: the loss of sales.
(c) Third, the plaintiffs claim that the defendants were, by virtue of their alleged acts of passing off, in breach of Clauses 2.3(2) and 2.3(3) of the Deed.
(d) Fourth, the plaintiffs claim that the defendants had conspired to injure the plaintiffs by incorporating the fourth defendant and by passing off the fourth defendant’s goods and services and their business as connected to the plaintiffs’ business.
(e) Fifth, the plaintiffs claim that the first defendant had wrongfully detained certain labels belonging to the second plaintiff (“the Labels”). This allegedly led to losses of $16,565.39.
- [53]
[53] The defendants deny the claims stated above.
The defendants’ counterclaims
- [54]
[54] The defendants’ counterclaims may be summarised as follows:
(a) First, the defendants claim that the plaintiffs and the Kohs had, by their use of signs identical or similar to the Malaysian DR. WHO quatrefoil device mark and the Malaysian DR. WHO word marks in Malaysia, through the procuring of bottled drinking water and the manufacture and printing of labels and boxes for bottled water from manufacturers other than the first defendant, acted in breach of Clause 2.3 of the Deed.
(b) Second, the plaintiffs and the Kohs had unlawfully conspired to injure the defendants by using the DR. WHO word marks and the DR. WHO quatrefoil device mark in Malaysia in breach of the Deed and the Malaysian Injunction. As part of this unlawful conspiracy, the plaintiffs brought the present suit with the intention of damaging the defendants’ business.
(c) Third, the first defendant claims that the second plaintiff owes it an outstanding amount of $143,665.80 following the first defendant’s supply of bottled water to the second plaintiff from January to May 2020.
(d) Fourth, the plaintiffs and the Kohs had wrongfully interfered with the defendants’ business with IKEA by demanding that IKEA cease and desist from the sale of the Cartons. According to the defendants, the use of the first defendant’s corporate name (“DR. WHO (M) SDN BHD”) or the defendants’ website (“www.drwho.asia”) did not amount to the use of the plaintiffs’ marks. There was thus no basis for the plaintiffs’ actions.
- [55]
[55] The plaintiffs deny the counterclaims above. The plaintiffs argue that they were justified in commencing the present suit and requesting IKEA to cease the sale of the Cartons. In addition, they take the position that the plaintiffs’ acts in Malaysia did not constitute breaches of the Deed as Clause 2.3 of the Deed only prohibits the supply, and not the manufacture, of bottled water by the plaintiffs in Malaysia.
Issues to be determined
- [56]
[56] For the plaintiffs’ claim, the following issues arise for my determination:
(a) whether the defendants have infringed the plaintiffs’ DR. WHO word marks and the DR. WHO quatrefoil device mark;
(b) whether the defendants have committed the tort of passing off ;
(c) whether the defendants have breached the Deed;
(d) whether the plaintiffs’ claim for unlawful conspiracy to injure is made out; and
(e) whether the defendants have wrongfully detained the Labels.
- [57]
[57] With respect to the defendants’ counterclaim, I will address the following issues:
(a) whether the plaintiffs have breached the Deed;
(b) whether the defendants’ claim for unlawful conspiracy to injure is made out;
(c) whether the second plaintiff is liable to the first defendant for the sum of $143,665.80; and
(d) whether the plaintiffs and the Kohs have wrongfully interfered with the defendant’s business with IKEA.
- [58]
[58] I deal with each issue in turn, beginning with the plaintiffs’ claim in trade mark infringement.
Claim 1: Infringement of the plaintiffs’ trade marks
- [59]
[59] The plaintiffs’ claims for trade mark infringement are premised upon s 27(2) of the TMA, which states as follows:
- [60]
[60] For a claim of trade mark infringement to succeed under s 27(2) of the TMA, the plaintiff must prove the following elements:
(a) use by the defendant(s) within Singapore’s territory (or, in cases where the allegedly infringing signs are found on websites, that consumers within Singapore have been “targeted” by these websites);
(b) in the course of trade;
(c) in a trade mark sense;
(d) without the consent of the plaintiff(s);
(e) a sign which is identical or similar to the registered mark;
(f) in relation to goods or services identical or similar to those for which the mark is registered; and
(g) a likelihood of confusion on the part of the public.
If, for the purposes of requirements (e) and (f), there exists an identity between the sign and the mark as well as between the respective goods or services, then the claim for trade mark infringement will be made out under s 27(1) of the TMA and there is no need for the plaintiff to satisfy requirement (g) pertaining to a likelihood of confusion on the part of the public.
- [61]
[61] The plaintiffs raise five instances of alleged trade mark infringement:
(a) The collective use of the DR. WHO quatrefoil device sign, the “www.drwho.com.my” sign and the “www.drwhohub.com” sign on the Commercial Vehicles and the use of the DR. WHO quatrefoil device sign on Driver A’s Attire;
(b) The use of the “www.drwho.asia” sign on the Cartons displayed for sale at IKEA Alexandra and IKEA Tampines;
(c) The use of the DR. WHO quatrefoil device sign, the copyright notice “© DR. WHO (S) PTE LTD” (“the Copyright Notice”), the meta-title “DR. WHO (M) SDN. BHD.” on the “www.drwho.com.my” website and the meta-title “DR. WHO (S) PTE LTD” on the “www.drwho.asia” website;
(d) The use of the DR. WHO quatrefoil device sign and the “Dr Who Malaysia” sign on the DR. WHO (M) Facebook page; and
(e) The use of the corporate name “DR. WHO (S) Pte Ltd” by the fourth defendant.
- [62]
[62] Before addressing these instances of infringement, I deal with three material aspects of the plaintiffs’ case.
- [63]
[63] First, despite the plaintiffs’ claims, no attempt was made in their submissions to compare (a) the goods or services in relation to which the various allegedly infringing signs were used with (b) the specifications that the DR. WHO quatrefoil device mark is registered for. The DR. WHO quatrefoil device mark is registered in respect of “water treatment units” in Class 11 and “the treatment of water” in Class 40. In the context of infringement proceedings, the task of the court is to engage in a comparison between the actual goods or services in relation to which the allegedly infringing signs were used, and the specifications of the trade mark(s) on the other: Sarika Connoisseur Cafe Pte Ltd v Ferrero SpA [2013] 1 SLR 531 (“Sarika”) at [46]. The burden therefore lies with the plaintiffs to prove that the infringing signs were used in relation to goods or services similar or identical to either “water treatment units” or “the treatment of water”.
- [64]
[64] The plaintiffs’ submissions on this matter are, however, regrettably threadbare. They amount only to an unsubstantiated assertion that such similarity or identity of goods or services exists vis-à-vis the DR. WHO quatrefoil device mark and the infringing signs simply by way of the fact that both the plaintiffs and the defendants are “suppliers of bottled water with label design and personalised branding”. I cannot accept this assertion. There is no evidence to show that the defendants had used the various signs in relation to the supply of “water treatment units”, “the treatment of water” or any other similar goods or services. Accordingly, the plaintiffs fail to discharge their burden of proof in relation to the similarity of goods or services registered under the DR. WHO quatrefoil device mark. The infringement claims in relation to the DR. WHO quatrefoil device mark must therefore be dismissed in their entirety.
- [65]
[65] Second, I deal with the plaintiffs’ infringement claim in relation to the DR. WHO services mark, which is registered in respect of the “delivery of bottled water to homes and offices” and “water supply services” in Class 39. The plaintiffs do not explain the similarity between this specification and the defendants’ actual use of the allegedly infringing signs. Instead, the plaintiffs simply state in their submissions that:
For the avoidance of doubt, nothing in “paragraphs 41 to 79” in the plaintiffs’ submissions deals with this issue either.
- [66]
[66] There is no evidence before me to show that the defendants were offering such delivery services (or any other similar services) to the public in Singapore under the allegedly infringing signs. For instance, the PI Report indicates that Vehicle A was seen at the first plaintiff’s office address and Global Water’s old and new premises while Vehicle B was present at Global Water’s old premises. However, the PI Report only captures the loading of empty bottles onto Vehicle A while it was present at Global Water’s premises on multiple occasions. This cannot be classified as the delivery of bottled water by these vehicles under the signs. The plaintiffs also do not direct me to content in the “www.drwho.com.my” and “www.drwho.asia” websites which indicates that such services were indeed offered by the defendants.
- [67]
[67] In addition, it appears disingenuous for the plaintiffs to point to the delivery made by Vehicle A to the premises of the first plaintiff under the signs as infringing use. This delivery, as admitted by the plaintiffs, was only made pursuant to the orders the plaintiffs had placed. Plainly, the use of the signs on Vehicle A would have been with the consent of the plaintiffs. There could therefore have been no confusion on the plaintiffs’ end regarding this delivery. I emphasise that this is a case where there is no evidence of the defendants offering such delivery services at all. The analysis may differ, however, if the defendants were in fact offering those services to the public and the plaintiffs simply placed (or caused to be placed) orders as evidence that such services were being offered. Instead, the delivery here was made pursuant to the longstanding commercial arrangement between the parties. It would therefore be unfair to refer to this instance as evidence that the defendants had delivered bottled water to customers in Singapore. For these reasons, the plaintiffs have not proved that the allegedly infringing signs have been used in relation to identical or similar services as the specification which the DR. WHO services mark is registered for.
- [68]
[68] Third, I accept that the plaintiffs did not consent (expressly or impliedly) to the use of the various signs listed at [61] by the defendants (“the complained-of acts”). The defendants argue that under the provisions of the Deed, they were “at liberty” to supply bottled water in Singapore as long as it did not contain the “word marks, DR WHO”. While not expressly articulated, this alludes to the argument that the plaintiffs had consented to the use of certain signs, such as the “www.drwho.asia” sign and the fourth defendant’s name on the Cartons, because such use was not expressly prohibited by the Deed. If such consent had been given, then liability cannot attach to the complained-of acts under s 27(2) of the TMA, which requires the use of a sign “without the consent of the proprietor of the trade mark”. This may also amount to a defence against the plaintiffs’ claim in passing off, assuming other conditions are met: see Christopher Wadlow, The Law of Passing Off: Unfair Competition by Misrepresentation (Sweet & Maxwell, 5th Ed, 2016) (“Wadlow”) at paras 9-106–9-108. In my view, however, a finding of such consent is not borne out by a proper interpretation of Clause 2.3 of the Deed.
- [69]
[69] Two competing interpretations of Clause 2.3 present themselves. The first interpretation is that Clause 2.3(2) provides for a distinct contractual obligation from Clauses 2.3(3) and 2.3(4). These provisions are reproduced below for ease of reference:
Under the first interpretation, the phrase “use the DR. WHO trademark” seems to refer to the use of any mark bearing the words “DR. WHO”. This follows from the fact that the surrounding provisions (Clauses 2.3(3) and 2.3(4)), which provide the context, make express reference to a “registered” mark – specificity which is conspicuously absent in Clause 2.3(2). Assuming Clause 2.3(2) provides for a distinct contractual obligation from Clauses 2.3(3) and 2.3(4), the word “use” in Clause 2.3(2), as further elaborated at [203] below, should also be understood to include acts involving the “DR. WHO trademark” beyond the direct or indirect supply of bottled water referenced in Clauses 2.3(3) and 2.3(4). On this reading of Clause 2.3, the complained-of acts, eg, the defendants’ use of the DR. WHO quatrefoil device sign, the “www.drwho.asia” sign and the fourth defendant’s name on the Commercial Vehicles, the Cartons and the websites, would ostensibly fall foul of Clause 2.3(2). In the absence of clear indications to the contrary, the plaintiffs could not have consented to acts which amount to a breach of the Deed. Liability under s 27(2) of the TMA may therefore still attach to the complained-of acts.
- [70]
[70] Under the second interpretation, Clause 2.3(2) is qualified by Clauses 2.3(3) and 2.3(4). This views Clauses 2.3(3) and 2.3(4) as circumscribing the specific instances of “use” which are prohibited under the Deed. In other words, Clauses 2.3(3) and 2.3(4) serve as explanations of Clause 2.3(2). The interpretation of the word “use” in Clause 2.3(2) is thus narrowed to the supply of bottled water bearing or under the registered trade marks and/or by way of passing off. Adopting this interpretation of Clause 2.3(2) read with Clause 2.3(3), however, leads to the same conclusion that there was no consent provided by the plaintiffs. The wording of Clause 2.3(2), read with Clause 2.3(3), only serves to restrict the defendants from carrying out certain acts. Even if the complained-of acts are not strictly prohibited by the contractual scope of Clause 2.3(2) read with Clause 2.3(3), it does not follow that the Deed goes further to provide consent for the defendants to use other signs containing the words “DR. WHO” or to use the registered trade marks on goods or services besides the “supply” of bottled water. The Deed does not, in its terms, provide any form of express consent or reflect which forms of conduct the parties have agreed to be permissible. Pertinently, the defendants also do not plead or argue for any specific construction of Clauses 2.3(2) and/or 2.3(3). They have not, for example, argued that the plaintiffs have impliedly consented to the defendants’ use of the various signs in Singapore by way of an implied term or otherwise. In these circumstances, I am of the opinion that the Deed does not provide consent for the defendants to use the various signs listed at [61]. As such, liability under s 27(2) of the TMA is not excluded and the lawfulness of the complained-of acts falls to be assessed by the general law governing trade mark infringement and passing off in Singapore. It is therefore clear that regardless of which interpretation of Clause 2.3 is taken, the plaintiffs have not provided any form of consent to the complained-of acts, which form the basis of the plaintiffs’ present claims for trade mark infringement and passing off.
- [71]
[71] Given the analysis in the preceding paragraphs, the following sections shall proceed to address the plaintiffs’ claims pertaining to each alleged instance of infringement only with respect to the DR. WHO goods mark.
Infringement Claim 1: The Commercial Vehicles and Driver A’s Attire
- [72]
[72] The following signs were allegedly used:
(a) The DR. WHO quatrefoil device sign on the Commercial Vehicles and on Driver A’s Attire;
(b) The “www.drwho.com.my” sign on the Commercial Vehicles; and
(c) The “www.drwhohub.com” sign on Vehicle B.
According to the plaintiffs, these signs infringed the DR. WHO goods mark.
Use of the allegedly infringing signs
- [73]
[73] As canvassed at [60], for a claim of trade mark infringement to succeed, the trade mark proprietor must establish (a) the use of an infringing sign within Singapore’s territory, (b) in the course of trade, (c) in a trade mark sense and (d) without the consent of the proprietor.
- [74]
[74] On the first requirement, the plaintiffs need to prove that the allegedly infringing signs were used in Singapore pursuant to the definition of “use” found in the TMA. Section 27(4) of the TMA provides:
The plaintiffs argue, presumably relying on s 27(4)(e) of the TMA, that the collective use of the signs on the Commercial Vehicles and Driver A’s Attire amounts to use in “advertising”.
- [75]
[75] I do not accept that the allegedly infringing signs on Vehicles C and D were used in Singapore. The requirement that the signs need to be used in Singapore stems from the fact that trade mark rights are territorial in nature. As such, use of a sign outside of Singapore generally cannot constitute an infringement under our local trade mark regime. Unlike Vehicles A and B, nothing in the evidence before me indicates that Vehicles C and D entered Singapore. The only evidence relating to Vehicles C and D is contained in the following paragraph of Mr Koh’s affidavit of evidence-in-chief:
Mr Koh’s evidence does not show that Vehicles C and D were sighted in Singapore. Instead, it suggests that these vehicles were sighted at the first defendant’s premises in Malaysia. The absence of evidence means that the plaintiffs have failed to prove the use of the allegedly infringing signs on Vehicles C and D in Singapore.
- [76]
[76] I am also not convinced by the plaintiffs’ evidence that the allegedly infringing signs were used in a trade mark sense on Vehicle B. The requirement of trade mark use concerns how the sign interacts with and is represented on goods: Burberry Ltd v Megastar Shipping Pte Ltd and anor [2019] 1 SLR 536 (“Burberry”) at [34]. According to the PI Report, Vehicle B was only sighted once on 7 May 2019 at Global Water’s old premises over a roughly six-month surveillance period. Only the following two photographs of Vehicle B were included in the report:
- [77]
[77] These photographs show that the allegedly infringing signs, namely the DR. WHO quatrefoil device sign, the “www.drwho.com.my” sign and the “www.drwhohub.com” sign (which reflected the plaintiffs’ website), were displayed on Vehicle B in an incomprehensible manner. This means that consumers who encountered the vehicle would not have been able to make out either the DR. WHO quatrefoil device sign, which sets out the name of the defendants’ undertaking, or the other two signs, which comprise the websites on which the relevant goods were displayed. Consumers would not have been directed to either the “www.drwho.com.my” website or the “www.drwhohub.com” website, and thus would not have seen the goods which the defendants and the plaintiffs are offering for sale. In other words, not only were the signs effectively not represented on any goods, but there was also no clear depiction of any source which consumers could be brought home to. Accordingly, the manner in which these signs were represented on Vehicle B rendered them incapable of being used in a trade mark sense.
- [78]
[78] Nevertheless, I am satisfied that the allegedly infringing signs were used in advertising on Vehicle A in Singapore. Vehicle A was sighted at Global Water’s old and new premises as well as the first plaintiff’s registered office address. Vehicle A would have been visible to the general public as it would have spent periods of time on the roads travelling between Singapore and Malaysia. The placement of the signs on Vehicle A therefore served to advertise the goods which these signs were used in relation to, which were displayed in the website reflected in the “www.drwho.com.my” sign. These signs were clearly used in the trade mark sense, as they served to denote the trade origin of the goods.
- [79]
[79] I do not, however, accept that the sign on Driver A’s Attire was used in Singapore for the purposes of advertising under s 27(4)(e) of the TMA. This is because the sign was placed on the back of Driver A’s Attire and would not be visible to members of the public viewing Vehicle A while the truck was moving on the road. According to the PI Report, the driver only dismounted at Global Water’s new premises to load empty bottles onto Vehicle A The private investigator from DP Quest (“the PI”) did not observe the driver interacting with anyone. The driver returned to the defendants’ premises in Malaysia promptly after the empty bottles were loaded.
- [80]
[80] There is no evidence on the present facts that the sign on Driver A’s Attire was intended to be displayed to any segment of the public in Singapore or, indeed, that any individual other than the PI (who was conducting surveillance) even saw the sign. Based on these facts, I am satisfied that the sign on Driver A’s Attire was not used in advertising pursuant to s 27(4)(e) of the TMA.
- [81]
[81] As the defendants do not seriously contest that the signs on Vehicle A have been used in advertising in the course of trade, I now turn to address the identity or similarity between the signs and the registered mark.
Identity/Similarity of the signs used
- [82]
[82] At this stage of the inquiry, the comparison is made between the mark as registered and the sign(s): see James Mellor et al, Kerly’s Law of Trade Marks and Trade Names (Sweet & Maxwell, 16th Ed, 2018) (“Kerly’s”) at para 16-071; City Chain Stores (S) Pte Ltd v Louis Vuitton Malletier [2010] 1 SLR 382 (“City Chain”) at [50]. This is done without consideration of any external matter: Staywell Hospitality Group Pty Ltd v Starwood Hotels & Resorts Worldwide, Inc and anor [2014] 1 SLR 911 (“Staywell”) at [20]. Three aspects of similarity are relevant: visual, aural and conceptual similarity. These aspects, however, are not to be treated as a mechanistic formula but involve the relative weighing of each aspect against the others. Similarity between the mark and the sign may thus be made out even if not all three aspects of similarity are made out: Hai Tong Co (Pte) Ltd v Ventree Singapore Pte Ltd and another and another appeal [2013] 2 SLR 941 (“Hai Tong”) at [40(a)]. This exercise is undertaken from the viewpoint of the average consumer who would exercise some care and a measure of good sense in making his or her purchases: Hai Tong at [40(c)]. This average consumer will also be deemed to be reasonably well-informed, reasonably observant and circumspect: Calvin Klein, Inc and anor v HS International Pte Ltd and others [2016] 5 SLR 1183 at [50(b)]. On the present facts, the comparison to be made is between the allegedly infringing signs and the DR. WHO goods mark.
(1) The DR. WHO quatrefoil device sign
- [83]
[83] I begin my analysis with the DR. WHO quatrefoil device sign which was present on Vehicle A. The comparison here is between the following:
and
- [84]
[84] I first assess the distinctiveness of the DR. WHO goods mark. The distinctiveness of a mark refers to its ability to serve as a badge of origin for specific goods or services: Hai Tong at [28]. It plays an integral role in the marks-similarity inquiry. A mark which bears greater distinctiveness will enjoy a higher threshold before a competing sign will be considered dissimilar to it: Staywell at [25]. Distinctiveness may arise either because the words used in a mark are completely inventive and meaningless or because even though they may have a meaning, they are used in a way that is completely arbitrary vis-à-vis the goods or services in question: Hai Tong at [31].
- [85]
[85] With regard to the DR. WHO goods mark, I am satisfied that “DR. WHO” is a purely inventive term that is made up and has no meaning at all. The word “DR.” is a prefix accorded to individuals who serve as doctors; the word “WHO” is an interrogative pronoun used typically in questions to enquire on the identity of a person. Taken together, the term “DR. WHO” bears no meaning by itself, as “WHO” appears to be used as a proper noun (the last name of a doctor) rather than as an interrogative pronoun. While the term “DR. WHO” may call to mind a popular television series, this has no discernable correlation to bottled or drinking water. The DR. WHO goods mark is therefore distinctive in so far as it is capable in effectively distinguishing the origin of the goods in question. It follows that the threshold to find that an allegedly infringing sign is dissimilar to the DR. WHO goods mark is high, and the distinctiveness of this mark will be accordingly integrated in the marks-similarity analysis which follows in this judgment (see Staywell at [30]).
- [86]
[86] One can hardly argue that the DR. WHO quatrefoil device sign is not similar to the DR. WHO goods mark (and the defendants rightly did not argue so). Apart from aural identity, the registered mark and the sign are also visually similar. Both the dominant components of the registered mark and the sign comprise the term “DR. WHO” in block letters. The slight differences in terms of font are also immaterial as the registration of a word in block letters covers the use of that word in any clearly legible form of lettering: Sarika at [24] citing Morny Ld’s Trade Marks, in the Matter of (1951) 68 RPC 131 at 149-–150. The presence of the quatrefoil-droplet device also does not militate against similarity when the mark and the sign are observed in totality as the element only appears as a relatively small and simple symbol at the end of the sign and is likely to be perceived only as a decorative element: see Hai Tong at [62(e)(i)]–[62(e)(vi)].
- [87]
[87] On conceptual similarity, the court must consider the ideas which lie behind or inform the mark or sign in question: Hai Tong at [70]. It is not immediately apparent what concepts the term “DR. WHO” may impart, though the prefix “DR.” may bring forth the concept of medical doctors and/or healthcare. I do not consider that the quatrefoil-droplet element present in the DR. WHO quatrefoil device sign adds or changes the conceptual nature of the sign. As both the sign and the mark are made up of the same term “DR. WHO”, they must logically contain the same concepts. I find, therefore, that there is conceptual similarity between the DR. WHO quatrefoil device sign and the DR. WHO goods mark.
- [88]
[88] In the round, the DR. WHO quatrefoil device sign and the DR. WHO goods mark are similar.
(2) The “www.drwho.com.my” sign
- [89]
[89] I turn now to the “www.drwho.com.my” sign which was used on Vehicle A. The comparison here is between the following:
www.drwho.com.my
and
- [90]
[90] The plaintiffs’ case is that the “www.drwho.com.my” sign is similar to the DR. WHO goods mark. The plaintiffs do not elaborate on this assertion of similarity, though it is presumed that it is the use of the term “drwho” that the plaintiffs take issue with.
- [91]
[91] Given that the “www.drwho.com.my” sign relates to a website address, an understanding of how the average consumer perceives the constituent “parts” of a website address (ie, domains) will be helpful in deciding if the “www.drwho.com.my” sign and the DR. WHO goods mark are similar. To this end, I borrow the helpful explanation in Christopher Morcom, Ashley Roughton & Thomas St Quintin, The Modern Law of Trade Marks (LexisNexis, 5th Ed, 2016) at para 17.9:
In the course of my analysis, I will adopt the acronyms for top-level domains (“TLDs”) and second-level domains (“SLDs”) used in the excerpt above.
- [92]
[92] Beginning with visual similarity, the dominant component of the “www.drwho.com.my” sign is its SLD, ie, “drwho”. This follows from the fact that the SLD identifies the “specific and unique administrative owner” associated with the address. Here, the SLD is visually similar to the DR. WHO goods mark. Both are made up of the same letters comprising the term “DR. WHO”. The fact that the SLD comprises letters in the lower-case while the DR. WHO goods mark comprises entirely capitalised letters is immaterial as a word mark registered in block letters covers the use of the relevant words in all legible forms of lettering and must not be confined to the mark’s representation in block capital letters: Sarika at [24]. The absence of the full-stop after the letters “dr” in the sign is also irrelevant. This is because full-stops (or dots) in a website address serve to separate subdomains. In other words, the functionality of the website address necessarily prevents the inclusion of the full-stop (or the dot). For the same reason, the lack of a space between the letters “dr” and “who” does not make a material difference, as a website address cannot function with an intervening space.
- [93]
[93] I am also not of the view that the TLD in the “www.drwho.com.my” sign (ie, “.com.my”) displaces the visual similarity between the dominant components of the sign and the mark. Some guidance may be gleaned from the English cases which deal with the infringement of registered trade marks by website addresses. In Argos Ltd v Argos Systems Inc [2017] EWHC 231 (Ch), the English High Court accepted at [8] and [37] that the infringing sign “Argos” used in the form of a website address (“www.argos.com”) was similar to the registered mark “ARGOS”. Similarly, in Tesco Stores Ltd v Elogicom Ltd and anor [2006] EWHC 403 (Ch) (“Tesco”), the English High Court held at [33] that signs in the form of website addresses, including “www.tesco2u.co.uk”, “www.tescodiet.com” and “www.tesco-jersey.com”, were similar to the registered marks “Tesco” and “Tesco.com”. These cases support the finding that the focus in a website address is on the SLD. It follows that the mere addition of a TLD or the use of a different TLD will typically be insufficient to render a sign comprising a website address dissimilar (visually or otherwise) to a registered mark (assuming such similarity is already established with the SLD). Therefore, despite the difference occasioned by the TLD in the “www.drwho.com.my” sign, it is my view that this sign is visually similar to the DR. WHO goods mark.
- [94]
[94] Similarly, the SLD of the “www.drwho.com.my” sign (“drwho”), which comprises its dominant component, is aurally identical to the DR. WHO goods mark. This is so because the five-letter term “drwho” cannot be comprehended in any other reasonable manner except to denote the words “DR. WHO”. While the TLD of the “www.drwho.com.my” sign adds a further aural component, I do not find this to be a significant difference, as evidenced from the conclusions made in the English cases above. The sign therefore bears aural similarity with the DR. WHO goods mark.
- [95]
[95] On conceptual similarity, I reiterate my finding above that the term “DR. WHO” appears not to have any inherent meaning but evokes the concepts of medical doctors or healthcare given the use of the prefix “DR”. Both the dominant components of the “www.drwho.com.my” sign (ie, its SLD “drwho”) and the DR. WHO goods mark share this conceptual feature. As no other ideas or concepts are contained within the sign and the mark, I find them to be conceptually similar.
- [96]
[96] For these reasons, I am satisfied that the “www.drwho.com.my” sign and the DR. WHO goods mark are similar.
Identity/Similarity of goods
- [97]
[97] Given my findings above that the DR. WHO quatrefoil device sign and the “www.drwho.com.my” sign are similar to the DR. WHO goods mark, I now consider whether these two signs were used in relation to goods identical or similar to those for which the mark is registered.
- [98]
[98] But what goods were the signs used in relation to? It bears emphasising that for the purposes of trade mark infringement, the signs must be used as indications of origin. This is because the inherent function of trade marks is to bring consumers home to the source of the goods or services in question: see Nation Fittings (M) Sdn Bhd v Oystertec plc and another suit [2006] 1 SLR(R) 712 at [62]. The underlying legal principle is therefore that a sign is used in relation to goods or services if an average consumer perceives the sign to be applied in that manner: Kerly’s at paras 16-038 and 16-040.
- [100]
[100] The question, then, is whether the goods (as reflected on the website) are similar or identical to the goods for which the DR. WHO goods mark is registered – Class 32 (for bottled water [not for medical purposes]; oxygenated water; drinking water; aerated water; waters [beverages] other than for medical purposes). The “www.drwho.com.my” website indicates that the defendants are “a key player in the drinking water industry” and that their “core business revolves around customised branding of PET bottles, Tetra Pak and aluminum [sic] cans based on individual clients’ requirements”. These goods are identical to the goods in respect of which the DR. WHO goods mark is registered. Given this identity between the goods in question, there is no further need to consider whether they are similar or the extent of their similarity: Staywell at [42] citing Susanna Leong, Intellectual Property Law of Singapore (Academy Publishing, 2012) at paras 28.354 and 28.358.
Likelihood of confusion
- [101]
[101] At this stage of the inquiry, what has to be established is a likelihood of confusion as to the origin of the goods in question. Confusion may either be direct, where the mark(s) and the sign(s) are mistaken for each other by the average consumer, or indirect, in which the similarities lead the average consumer to form the mistaken view that they originate from the same or linked undertakings: Kerly’s at para 16-091; Hai Tong at [73]. This inquiry is undertaken from the same viewpoint as that for the inquiry on mark-similarity – that of the average consumer: Hai Tong at [40(c)]. The likelihood of confusion that is required is that to be expected amongst a substantial portion of the relevant public. This need not amount to a majority but must go beyond a “de minimis” level: Hai Tong at [78(e)] citing Sarika at [57]. The relevant public comprises the actual or potential purchasers of the goods in question, and those who deal with these goods: Ng-Loy Wee Loon, Law of Intellectual Property of Singapore (Sweet & Maxwell, 3rd Ed, 2022) at para 21.5.27. This will include the actual or potential purchasers of the goods of the plaintiff and the defendant: see Digi International v Teraoka Seiko Co, Ltd [2021] SGHC 165 (“Digi”) at [174].
- [102]
[102] In Staywell, the Court of Appeal held at [95] that the factors that may generally be taken into account in this inquiry are those intrinsic to the nature of the goods or services and/or which affect the impact that the similarity of the marks and the goods/services has on the consumer. The court proceeded to set out a non-exhaustive list of these factors at [96]:
(a) Factors relating to the impact of mark-similarity on consumer perception:
(i) degree of similarity of the mark themselves;
(ii) the reputation of the marks;
(iii) the impression given by the marks; and
(iv) the possibility of imperfect recollection of the marks.
(b) Factors relating to the impact of goods/services-similarity on consumer perception:
(i) the normal way in or the circumstances under which consumers would purchase goods/services of that type;
(ii) the price of the goods/services (as opposed to the price disparity between the competing goods);
(iii) the nature of the goods/services and whether they would tend to command a greater or lesser degree of fastidiousness and attention on the part of prospective purchasers; and
(iv) the likely characteristics of the relevant consumers and whether they would or would not tend to apply care or have specialist knowledge in making the purchase.
- [103]
[103] I assess the likelihood of confusion arising from the use of the DR. WHO quatrefoil device sign and the “www.drwho.com.my” sign on Vehicle A (as displayed below).
The relevant public here will comprise consumers who have seen the signs and visited the “www.drwho.com.my” website. These consumers may be categorised into two further classes: (a) the potential end users of the plaintiffs’ and the defendants’ goods as well as (b) traders who are potential customers of the plaintiffs and the defendants (see, eg, Hearst Holdings Inc v AVELA Inc [2014] EWHC 439 (Ch) at [72]–[75]). The level of attention and care paid by the average consumer in each class will differ based on the knowledge, experience and purchase involvement of the relevant class: Kerly’s at para 3-016. While traders are likely to pay a higher degree of attention and care toward their purchases, this does not, on the present facts, affect the analysis pertaining to the confusion inquiry.
- [104]
[104] I take as a starting point my findings above that the DR. WHO goods mark is similar to the DR. WHO quatrefoil device sign and the “www.drwho.com.my” sign. The likelihood of confusion arises upon the average consumer in both classes viewing the goods for sale on the website reflected in the “www.drwho.com.my” sign. These goods, as mentioned at [100], are identical to the goods which the DR. WHO goods mark is registered for. The home page of the “www.drwho.com.my” website also indicates that the defendants’ undertaking serves clientele in both Singapore and Malaysia. At this point, the relevant public will be under the impression that the goods which are advertised under the signs originate from the Malaysian branch of the undertaking operating under the registered mark.
The judgment continues past this page. Read the rest at eLitigation.